Skip to main content

(βS,3R)-β-[3-(3,5-Dimethyl-1H-pyrazol-1-yl)phenyl]-3-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl]-1-pyrrolidinebutanoic acid

Chemical FDA Substance Registry (openFDA)
Chemical Identification
CAS Number1629249-33-7
INCI Name(3S)-3-[3-(3,5-dimethylpyrazol-1-yl)phenyl]-4-[(3R)-3-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl]pyrrolidin-1-yl]butanoic acid
PubChem CID 86272865
Molecular FormulaC29H37N5O2
InChIKeyInChI=1S/C29H37N5O2/c1-20-1
SMILESCC1=CC(=NN1C2=CC=CC(=C2)[C@H](CC(=O)O)CN3CC[C@H](C3)CCC4=NC5=C(CCCN5)C=C4)C
Known Aliases (3)
Common Name
GSK-3008348 FREE BASE GSK3008348 FREE BASE
Scientific Name
1-Pyrrolidinebutanoic acid, β-[3-(3,5-dimethyl-1H-pyrazol-1-yl)phenyl]-3-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl]-, (βS,3R)-
Data Sources (1)
Source Source ID Name in Source Properties
FDA Substance Registry (openFDA) L6EE7H64YF (βS,3R)-β-[3-(3,5-Dimethyl-1H-pyrazol-1-yl)phenyl]-3-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl]-1-pyrrolidinebutanoic acid CAS: 1629249-33-7
SMS_ID: 300000042457
PUBCHEM: 86272865
FDA UNII: L6EE7H64YF
Record Info
IDeetoRyCK9LwzgoavVmzHBm
CreatedApril 10, 2026, 9:32 p.m.
ModifiedApril 10, 2026, 9:32 p.m.
EnrichedApril 11, 2026, 12:09 a.m.
Data SourceFDA Substance Registry (openFDA)